SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-22-075291
Filing Date
2022-11-25
Accepted
2022-11-25 16:59:57
Documents
15
Period of Report
2022-07-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K f10k2022a1_enzobio.htm   iXBRL 10-K/A 339939
2 CERTIFICATION f10k2022a1ex31-1_enzobio.htm EX-31.1 10199
3 CERTIFICATION f10k2022a1ex31-2_enzobio.htm EX-31.2 10438
  Complete submission text file 0001213900-22-075291.txt   625573

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE enz-20220731.xsd EX-101.SCH 3203
5 XBRL DEFINITION FILE enz-20220731_def.xml EX-101.DEF 16510
6 XBRL LABEL FILE enz-20220731_lab.xml EX-101.LAB 33853
7 XBRL PRESENTATION FILE enz-20220731_pre.xml EX-101.PRE 17526
9 EXTRACTED XBRL INSTANCE DOCUMENT f10k2022a1_enzobio_htm.xml XML 6361
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-K/A | Act: 34 | File No.: 001-09974 | Film No.: 221420694
SIC: 8071 Services-Medical Laboratories